RIVM, the collective Municipal Public Health Services (GGDs) in collaboration with GGD GHOR, the NIVEL Netherlands Institute for Health Services Research and ARQ National Psychotrauma Centre have developed a new monitor: the Integrated Health Monitor

The percentage of children receiving vaccinations from the National Immunisation Programme rose again last year. Another striking note is the 10% increase in HPV vaccination, rising to 63%.

In order to achieve an accurate overview of how often respiratory infections occur in the Netherlands, it is important to know how many patients are admitted to hospital with a respiratory infection.

Vaccination coverage in the Netherlands rose more sharply this week than in previous weeks, increasing to 81.7% among people aged 18 years and older and 79.0% among those aged 12 years and older.

RIVM is providing access to COVID-19 vaccination figures by municipality via open data as of today.  The open data now includes vaccination turnout and coverage by municipality for three age groups.

Inno4vac, a new European interdisciplinary project was launched on 1 September. Inno4vac focuses on the design and application of new and highly advanced predictive models to allow a faster development and manufacturing of new vaccines.

Last year, the incidence of tuberculosis (TB) in the Netherlands fell sharply. The 17% drop is the largest in fifty years. In 2020, 623 cases were notified compared to 754 in 2019.

The method developed by RIVM to assess whether waste treatment is sufficiently safe and sustainable, can contribute to the European ambitions for a safe and more circular economy.

The Ministry of Health, Welfare and Sport (VWS) has decided to resume vaccinating with the COVID-19 vaccine made by AstraZeneca within the near future.

Starting tomorrow, the first people in the age group from 75-79 years will receive an invitation from RIVM for a COVID-19 vaccination. These people were born in the years from 1941 through 1946.